Amrize Ltd (AMRZ) executive receives 4,256-share performance award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amrize Ltd reported that Chief Strategy & M&A Officer Samuel Jonas Poletti acquired 4,256 ordinary shares on a grant/award basis at no cost. The shares were issued upon settlement of performance stock units originally granted under Holcim Ltd equity awards converted in connection with the Amrize spin-off. Following this settlement, his directly held stake increased to 7,645 ordinary shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Poletti Samuel Jonas
Role
Chief Strategy & M&A Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 4,256 | $0.00 | -- |
Holdings After Transaction:
Ordinary Shares — 7,645 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Amrize Ltd (AMRZ) report for Samuel Jonas Poletti?
Amrize Ltd reported that Chief Strategy & M&A Officer Samuel Jonas Poletti received 4,256 ordinary shares as a grant/award. The shares came from settling performance stock units tied to legacy Holcim equity awards converted during the Amrize spin-off.
Was the Amrize (AMRZ) award to Samuel Jonas Poletti based on performance?
Yes. The settled performance stock units that delivered 4,256 Amrize shares vested based on the performance of Holcim and Amrize. The performance period ran from January 1, 2023 through December 31, 2025, aligning the award with multi-year company performance metrics.